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ABSTRACT
Upon anesthesia induction, patients often receive fentanyl, an opioid medication
that is linked to addiction, dependence, morbidity, and mortality (Stanley, 2014). The
goal of this practice recommendation was to propose an alternative way of managing pain
and the increased sympathetic response in the perioperative setting, specifically during
the induction phase, through evaluating published research. A possible substitute for
fentanyl is a drug called dexmedetomidine (Precedex™). Through a comparison of
pharmacology, indications, risks, and benefits, one can conclude that if Precedex™ is
given prior to induction, in the place of large doses of fentanyl, it can potentially achieve
a smoother intraoperative period through promoting decreased sympathetic stimulation
and a maintained respiratory drive (Gaszynski et al., 2014). The goal was to provide a
literature-based, relevant practice recommendation for anesthesia providers who are open
to changing their daily practice. The hope was that the recommendation will serve as a
clear reference regarding the risks and benefits of dexmedetomidine, as well as the
benefits and potentially detrimental side effects of fentanyl in their practice.
The proposed practice recommendation was formulated into a three-page handout
that detailed the highlights of our research regarding this topic. We presented this
handout via email to all CRNAs at a central Mississippi hospital. This handout was read
and evaluated by willing CRNAs who subsequently completed a survey consisting of
closed-ended questions. These questions inquired about relevance, availability, and
willingness to adopt the practice recommendation into clinical practice.
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CHAPTER I - INTRODUCTION
If a patient is receiving a general anesthetic, the period immediately prior to
surgical incision is known as the induction period. During the induction period, patients
receive intravenous drugs that aid in sedation, paralysis, amnesia, and attenuated pain
responses. Fentanyl is an opioid medication that is commonly chosen to give during
induction by anesthesia providers. Ideally, the drug will inflict sedation, hemodynamic
stability, and diminished stress responses that occur when the body is stimulated with an
endotracheal tube in the trachea or skin incision (Lee & Yeomans, 2014). However,
current research provides concerning evidence regarding the side effects related to
fentanyl. Fentanyl is linked to addiction, dependence, morbidity, and mortality.
Armaghani et al. (2014) conducted a prospective cohort study that demonstrated that
greater preoperative use of opioid medications predicted an increasing need for opioids
during the recovery period. Armaghani et al.’s (2014) evidence predicts that the
independent administration of preoperative fentanyl is merely serving as a short-term
solution.
The goal of this doctoral project was to propose a superior way of achieving an
adequate depth of anesthesia and reduced operative stress. The proposal included that
multimodal drug therapy can diminish or abolish the necessity for opioid medications.
Precedex is a non-opioid intravenous medication designed to achieve sedation and pain
control in patients. If given prior to induction, in the place of large doses of fentanyl,
Precedex can achieve patient comfort and safety, while also preventing the detrimental
side effects of opioids.
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Problem Description
Fentanyl was introduced in 1960, more than 50 years ago (Stanley, 2014), and is,
therefore, a familiar drug to anesthesia providers. Fentanyl is potent, fast-acting, and
inexpensive. Therefore, according to Stanley (2014), fentanyl is now the most frequently
administered analgesic given in a surgical setting. Fentanyl is linked to many short-term
and long-term adverse effects, including temporary implications, such as pruritus and
respiratory depression, as well as life-altering effects, such as addiction.
Dexmedetomidine (Precedex) is a newer medication that is rapidly acquiring
popularity among anesthesia providers. Precedex has an advantage over fentanyl “for
its sympatholytic, sedative, anesthetic sparing, and hemodynamic stabilizing properties
without significant respiratory depression” (Keniya et al., 2011, p. 352). The hope was to
suggest and educate anesthesia providers on alternative means of patient comfort and
safety by preoperatively utilizing this comparably efficient drug. The formulation of this
suggestion was done through a comparison of pharmacology, indications, risks, and
benefits. Ideally, anesthesia providers acquired an improved understanding of the risks
and benefits of dexmedetomidine, as well as the benefits and potentially detrimental side
effects of fentanyl. Further, if the ideas that follow were applied to day-to-day anesthesia
practice, patients ideally benefited from enhanced evidence-based care.
Clinical Question
A clinical question was developed to provide an encapsulated objective of the
information provided in this doctoral project. This question provided the reader with the
targeted population and proposed intervention. For patients undergoing general
anesthesia, does the use of dexmedetomidine (Precedex) before intubation and surgical
2

incision provide hemodynamic stability, patient comfort, and necessary level of
anesthesia, comparable to that of fentanyl, and therefore a decreased or abolished
necessity of fentanyl during the interoperative period?
Background and Significance
The opioid crisis in America is a topic that many Americans are becoming
increasingly more aware of. This awareness can be attributed to the fact that the number
of unintended deaths related to opioids actually exceeds the number of deaths related to
motor vehicle accidents. The lesser-known truth is that many of the victim's first
encounters with the medication are during the surgical period. The use of opioids in the
medical community has risen over the last three decades and continues to do so (Stanley,
2014).
This crisis has paved a route to researching new methods of pain control for
patients requiring surgical intervention. These methods are new and continuing to
improve with trial and error. Techniques include enhanced recovery pathways, regional
anesthesia, and multimodal analgesia. While research supports the use of these alternative
pain control methods, these methods often require an increased hospital budget,
specialized education for providers, and time constraints on perioperative periods
(Velasco, 2019). The goal of this doctoral project was to educate providers and prove the
benefits of Precedex, an alternative preoperative medication. Evidence is provided
below that Precedex can navigate the barriers of timely care and adverse effects.
Theoretical Framework
For this doctoral project, the Donabedian Quality of Care Framework was
utilized. This framework assesses the quality of care through three categories: structure,
3

process, and outcomes (Ayanian & Markel, 2016). Utilizing the Donabedian framework,
the practice guidelines include aspects that affect the context in which health care is
given. For the doctoral project, a practice change presentation occurred at a Mississippi
hospital among certified registered nurse anesthetists (CRNA) that were willing to
entertain new and efficient preoperative care strategies. The process encompassed the
actions taken. The change began with the introduction to the recommended use of
Precedex for anesthesia providers. No patient-provider interaction was required for this
doctoral project, but evidence-based practice guidelines were provided and available for
consideration. The guidelines included clear and concise benefits of correctly
administering the medication preoperatively. The outcome component stemmed from the
assessment provided by anesthesia providers who received this information. The
provided material and subsequent survey dictated whether this information would, or
would not, impact the individual’s practice, and positively affect patient surgical
outcomes.
Doctor of Nursing Practice Essentials
The foundation for all doctoral projects is the eight Essentials of Doctor of
Nursing Practice (DNP). These eight Essentials guided each aspect of this doctoral
project. Specifically, every aspect of Essential three was met as it reflects the doctoral
project’s purpose of using the advanced research of scholarly, evidence-based articles and
translates them into a best practice recommendation that has the potential to improve
patient care outcomes. Discovery of new-age knowledge and practices related to the uses
of Precedex, along with minimizing the use of fentanyl, allows providers the expertise
to integrate these practices into complex anesthetic situations. The best practice
4

recommendation also met the elements of Essential three by providing an avenue for
DNP graduates to engage in the progression of advanced practice nursing and become
leaders in evidence-based practices (Curley et al., 2016). One other Essential that the
recommendation aimed to achieve was Essential Six: Interprofessional Collaboration for
Improving Patient and Population Health Outcome. Through a survey tool, input was
sought from seasoned anesthesia providers. This collaboration of experience among
students and providers is one that evidence-based research alone cannot provide (Curley
et al., 2016). Refer to Appendix F for details on each Essential, as well as how the
Essentials were fulfilled by the evidence provided in this doctoral project.
Review of the Evidence
A literature review was performed to provide readers with the most up-to-date and
relevant evidence-based information. Articles related to fentanyl given before surgical
incision, Precedex given prior to surgical incision, and the number of perioperative
opioids and pain control that was subsequently needed were collected. Search engines
included but were not limited to, Google Scholar, Academic Search Premier, Medline,
and EBSCO. Publications were filtered to include only literature that was written in the
last seven years (with exclusions for exceptional data without revisions in recent years),
full-text and peer-reviewed, and available in the English language. Keywords used in the
search included: preoperative fentanyl, preoperative Precedex, opioid-free general
anesthesia, fentanyl substitution, anesthesia, and pain control. Only articles that provided
relevant information on the preoperative use of these two medications during general
anesthesia were included. Studies that did not meet the criteria were excluded.
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Fentanyl Pharmacology and Associated Systemic Effects
Although fentanyl’s ability to be administered in multiple formulations
(intramuscular, transdermal, intranasal, and intrathecal) is one of the reasons this drug is
so widely utilized, this recommendation focuses solely on intravenous fentanyl as it is
most frequently delivered via this route during the operative period. Fentanyl was the first
drug synthetically designed in a class of mu receptor-stimulating opioids. Its onset of
action is dose-dependent and can be achieved in as little as one minute when given
intravenously. “Significant analgesia may occur with fentanyl plasma concentrations as
low as 0.2 mcg/kg in patients who are opioid-naïve patients” (Stanley, 2014, p. 1217). Its
duration of action is usually two to four hours.
Systemic effects of fentanyl are associated with its mu-receptor stimulation in the
central nervous system. One must consider opioid-naïve patients and dosage, as the side
effects are directly correlated to these two factors. Side effects include fatigue or
sedation, vomiting, dizziness, respiratory depression or apnea, bradycardia, and
unconsciousness at high doses. If given quickly, life-threatening chest wall rigidity can be
obtained with doses as low as 50 mcg (Stanley, 2014). While the mild side effects of
fentanyl, such as nausea, fatigue, and constipation are not interpreted as detrimental to
patients, these side effects can be paramount to the recovery of post-operative patients.
Fentanyl is metabolized by the human cytochrome P450 isoenzyme. The P450
isoenzyme is important because many other drugs also utilize this enzyme. Therefore,
there is the potential for pharmacological interactions to occur when fentanyl is combined
with protease inhibitors. such as Fluconazole and Diltiazem. The result is an increased
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fentanyl plasma concentration and resultant signs of an opioid overdose, specifically
respiratory depression (Stanley, 2014).
Current Use
Clinical use of fentanyl, as stated above, is dose-dependent. Small doses (1-2
mcg/kg) are frequently administered to produce analgesia. Prior to surgery, 2-20 mcg/kg
of fentanyl is often given before laryngoscopy or surgical stimulation to blunt circulatory
response. The goal of this high dose given immediately prior to surgery is to avoid
increased doses of inhaled anesthetic as well as subsequent doses of opioids during the
post-operative period for severe pain. Further, it has been found that the dose of
isoflurane, desflurane, and nitrous oxide given subsequently is decreased after a patient
has received fentanyl. Even larger doses, up to 150 mcg/kg is used as the sole anesthetic
for patients who are unable to tolerate the myocardial and/or histamine related effects of
other anesthetic drugs. It is important to note that fentanyl will not prevent 100% of
sympathetic response to stimuli and there is a potential for postoperative ventilator
dependence (Stoelting et al., 2013). The average wholesale price of a 250 mcg vial of
fentanyl is $2.15 (Ibinson & Metro, 2012).
Precedex Pharmacology and Associated Systemic Effects
Precedex, a much newer drug compared to fentanyl, was approved for clinical
use in 1999 for short-term sedation. Precedex is a unique sedation agent as it is
classified as an alpha-2 adrenoceptor agonist. Although all of the mechanisms of
analgesic actions of stimulation of the alpha-2 receptor have not been identified, it is
known that it inhibits adenylate cyclase, hyperpolarizes the cell membranes, and
suppresses calcium entry into the nerve terminal, thereby inhibiting the release of
7

stimulating neurotransmitters. The negative feedback of the presynaptic neurotransmitters
terminates pain signals, while inhibition of the postsynaptic neurotransmitters depresses
the central nervous system. Since Precedex has the ability to work at both of these sites
(in a dose-dependent fashion), it can produce analgesia, anxiolysis, and sedation. (Gertler
et al., 2001).
Precedex is also available in many formulations (intravenous, intramuscular,
spinal, epidural, peripheral nerve block, buccal, and intranasal), but this practice
recommendation focuses solely on the intravenous administration. Dexmedetomidine has
a slower onset than fentanyl of about six minutes. Its peak is fifteen minutes and its
duration of action is dose-dependent (Naaz & Ozair, 2014). A loading dose of 0.5 to 1.0
mcg/kg for 10 minutes is recommended (Sim et al., 2014). A dose of 0.2 to 0.7 mcg/kg/hr
via IV infusion allows for a steady state of linear kinetics. Precedex is 94% proteinbound, there are no active metabolites, and it is excreted mainly in the urine.
Biotransformation involves cytochrome P450 and glucuronidation. One should note that
the dose should be reduced in patients with hepatic and renal impairment (Nagelhout &
Elisha, 2018).
Dexmedetomidine is considered a cardiovascular sympatholytic, although, upon
initial bolus, hypertension and bradycardia can occur with rebound hypotension and
tachycardia, which can rarely lead to arrhythmias such as AV block. Precedex does not
cause respiratory depression. Other effects that can be expected from the inhibition of
neuronal firing include decreased salivation, decreased gastric motility, inhibited renin
release, increased release of both sodium and water from kidneys, decreased intraocular
pressure, and decreased insulin release (Haselman, 2008).
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Precedex is considered a neuroprotectant. Motor and somatosensory evoked
potentials are maintained, cerebral metabolism does not decrease, and cerebral blood
flow is lower. The anesthetic-sparing techniques allow for improvement in both
withdrawal symptoms and brain and spinal cord level trauma. This technique is accepted,
yet still undergoing further research (Nagelhout & Elisha, 2018).
Miscellaneous effects that occur with the administration of dexmedetomidine
include mild diuresis due to the stimulation of the alpha-2 receptor. Precedex is also
considered gastroprotective and an anti-inflammatory. In both children and adults, the
incidence of emergence delirium is much lower when dexmedetomidine is utilized
(Nagelhout & Elisha, 2018).
Current Use
Although the effects of alpha-2 receptor agonists have long been utilized by
veterinarians, until 1999, drugs in this class of medication were not used on humans for
sedation purposes until the introduction Precedex (dexmedetomidine).
Dexmedetomidine is useful in that it can provide both analgesia and sedation for entire
perioperative periods. Precedex has applications as a surgical premedication as it
maintains respirations and response to carbon dioxide. It decreases oxygen consumption
by up to 8% (Naaz & Ozair, 2014).
Precedex’s interoperative uses are vast. Dexmedetomidine decreases the stress
response to tracheal intubation through its antagonistic sympathetic actions. The sedation
is said to be comparable to natural sleep, therefore the patient can be awakened for neuro
tests readily. Precedex is widely utilized in procedural sedation as it allows improved
tolerance and agitation without requiring the need for an established airway. Precedex
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is often administered at the conclusion of major surgery, as it renders the patient sedated,
yet cooperative and tolerant upon stimulation (Nagelhout & Elisha, 2018). The average
wholesale price of a 2 mg vial of Precedex is $78.00, making it one of the most
expensive vials of intravenous medication (Ibinson & Metro, 2012).
Another indication for Precedex, one which fentanyl would not be able to
facilitate, is an awake intubation. An awake intubation is occasionally done for patients at
high risk for respiratory arrest on induction. A study by Gaszynski et al. (2014), found
that dexmedetomidine given before awake intubation allowed a patient to maintain a
spontaneous respiratory pattern and decreased sympathetic response to stimulation.
Patient Safety and Efficacy
Patient safety under the care of an anesthesia provider requires the continuation of
a patient's homeostatic state. To achieve homeostasis, one must avoid errors that lead to
adverse outcomes and provide an anesthetic that not only physically protects the patient
but also psychologically leaves the patient unaltered. Opioid medications, including
fentanyl, have long been regarded as one of the most high-risk medications administered
with almost every anesthetic. Opioids carry negative implications both in the operating
room and outside of it, hence the opioid crisis in the United States. Opioid sparing
techniques are currently being developed utilizing multimodal therapies that aim to
provide patients with a comparable experience that avoids opioids side effects. These
effects include, but are not limited to, abuse. Many of these techniques are elaborate
and/or expensive. The hypothesis is that anesthesia providers may decide, after reading
the provided information, that the utilization of a replacement drug could produce more
obtainable daily results.
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Anesthesia providers have to balance patient satisfaction and drug side effects
daily. Often, the adverse events from effects such as respiratory depression and resultant
brain damage outweigh patient comfort. Dexmedetomidine has a unique profile that
allows for the degree of sedation and analgesia patients prefer while also avoiding the
adverse effects. When compared to other sedatives, Precedex has been shown to not
only be safer, but more efficient in producing patient satisfaction (Chan et al., 2016). A
study by Gupta et al. (2018) found that during a randomized clinical study that compared
fentanyl and dexmedetomidine use during induction, for patients who received 1 mcg/kg
of fentanyl on anesthesia induction with a laryngeal mask airway, apnea time was
significantly longer following induction than it was with dexmedetomidine.
Mortality and Morbidity
The same properties that make fentanyl so useful for hospital use are the same
properties that have aided inpatient abuse. Opioids are desirable for addicts due to their
central nervous system action, high potency, and quick onset of action. Beginning in
1979, fentanyl derivatives have been used to enhance street drugs, such as Heroin, to
make them more affordable and to create and increased potency for abusers (Krenzelok,
2017). The neuroanatomical structures that are stimulated with the drug control
Dopamine, the reward center of the brain, which gives the user a feeling of exhilaration
and relaxation. This reward center stimulation is the aspect that makes fentanyl even
more ideal for the drug abuser (Ramos-Matos & Lopez-Ojeda, 2018). The increase in
illicit use and inappropriate prescriptions by physicians has led to a marked increase in
opioid mortality in the United States and a necessity to identify its appropriate and
inappropriate use of the medication.
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Unlike fentanyl, the drug abuse and dependence potential for Precedex outside
of the hospital environment has not been studied in humans. Animal studies have shown
that there is a potential for a withdrawal-like syndrome if abruptly discontinued. The
withdrawal syndrome can be attributed to the rapid rise in catecholamines. A drug
euphoria comes from the stimulation of the central nervous system. Therefore, because
Precedex depresses sympathetic activity (unlike fentanyl, which stimulates the CNS),
there are minimal, or zero benefits to a drug abuser with the use of Precedex (Naaz &
Ozair, 2014).
As noted above, Precedex promotes a slight decrease in the cardiovascular
system. Therefore, it should be avoided in patients with severe heart block or an ejection
fraction of less than 30%. If a patient is hypovolemic, this patient will need to return to
baseline before starting dexmedetomidine therapy. Bolus doses are cautioned. One should
be aware that its amnesic properties are not as strong as drugs such as fentanyl, therefore
recall is possible (Naaz & Ozair, 2014).
Specific Aims
The purpose of this doctoral project was to propose an alternative route to
achieving a blunted sympathetic response during surgical procedures by developing a
best practice recommendation based on literature findings. The specific aim of
researching fentanyl and dexmedetomidine was that although both drugs are available for
use in most hospital operating rooms, serious complications have arisen from the
exponentially increasing use of intraoperative fentanyl. Precedex is a newer drug with
less research backing its use. It is currently utilized in a multitude of situations
successfully but has no established place in the interoperative period. Therefore, the goal
12

of achieving an increase in Precedex use and a decrease in fentanyl use will depend on
the validity of the literature contained in the practice recommendation and the recipient
anesthesia providers' receptiveness, manor, and setting of practice, and previous
experiences. Over the years, drugs have come and gone in order the meet the consistently
changing demands of clinical practice. The hope was to streamline the methods that
pharmaceutical information has previously been provided to healthcare practitioners into
a simple practice recommendation that would eventually result in improved patient safety
and quality of care.
Summary
Diminished airway reflexes, a stable cardiovascular system, and a relaxed patient
are pertinent to a smooth induction for a general anesthetic. Fentanyl and Precedex are
two drugs that if appropriately used can provide this for anesthesia professionals.
Fentanyl is an older drug with an arguably simpler mechanism of action and is more
familiar to most seasoned anesthesia providers. Precedex is a newer drug, and while
most of its mechanism of action is known and understood, much about its place in the
operating room is still being investigated. The hope is to bridge this gap in research by
supporting the use of dexmedetomidine (Precedex) before intubation and surgical
incision to provide hemodynamic stability, patient comfort, and necessary level of
anesthesia, comparable to that of fentanyl, and therefore a decreased or abolished
necessity of fentanyl during the interoperative period.
In summary, fentanyl works through stimulating receptors (mu, kappa, delta)
(Stanley, 2014). Precedex works through blocking receptors that otherwise would
release stimulating neurotransmitters (norepinephrine) utilized (Nagelhout & Elisha,
13

2018). Fentanyl carries a risk of abuse that Precedex does not. Fentanyl is more rapidacting than Precedex and approved for chronic pain (Stanley 2014). Precedex is only
approved for acute pain (less than twenty-four hours), but useful in maintaining
spontaneous respirations (Gertler et al., 2001). Fentanyl has limitations such as
respiratory dependence, sympathetic stimulation, histamine release (Stanley, 2014).
Precedex has limitations such as cardiac depression and cost (Naaz & Ozair, 2014).
Each of these two drugs has a place in modern health care. An educated provider should
assess individual situations and patients, weigh the pros and cons of each drug, and make
an informed choice on which induction medication will provide the best possible care for
their patient.
Proposing this pharmaceutical change practice recommendation was done in
hopes that patient safety would improve through the help of a guideline related to drug
choice. The recommendation supports quicker recovery times, shorter hospital stays, and
decreased morbidities and mortalities related to fentanyl overuse. Therefore, the purpose
of this doctoral project was to develop a best practice recommendation based on current,
relevant knowledge regarding intraoperative pharmacologic measures of decreasing
sympathetic stimulation during the intraoperative period.
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CHAPTER II - METHODOLOGY
Many steps were taken to create a best practice recommendation and complete
this doctoral project. To begin the doctoral project, a project proposal was presented to
the project chair and project committee. Following proposal approval, the development of
the best practice recommendation began. This best practice recommendation consisted of
a three-page, summarized, evidence-based handout. Next, an application for the
Institutional Review Board (IRB) approval from The University of Southern Mississippi
was completed and approved (IRB-20-236).
After receiving IRB approval, the specific clinical site was given a proposal for
the need for change, and approval to acquire participation from employees was given.
The hospital site that was chosen is located in central Mississippi. The hospital site is a
comprehensive care and surgical center that specialties include cardiovascular, obstetric,
oncologic, neurologic, and pulmonic care. Further, this hospital site has been recognized
with numerous awards for success in quality and patient safety improvements. The next
step was to formulate an expert panel to review the guidelines created for the best
practice recommendation and provide crucial feedback. CRNAs and anesthesiologists
together are the primary personnel involved in theoretically incorporating the guidelines
into practice; therefore, these anesthesia providers are the keys to the success of the
practice recommendation. These anesthesia providers are responsible for administering
both fentanyl and/or Precedex in the surgical setting. In the Mississippi hospital site,
CRNAs, in addition to anesthesiologists, all independently make decisions under medical
supervision regarding personal usage of these two drugs for patients. Specifically, the
panel that this best practice recommendation was proposed to include a chief CRNA,
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staff CRNAs, and staff anesthesiologists. The aim was to present to and acquire feedback
from a minimum of ten providers.
Construction of the final recommendation guidelines compiled research of current
literature related to the best practices in connection with the doctoral project topic,
examination of current practices by CRNAs and anesthesiologists within a Mississippi
Hospital clinical site, and post-presentation input from participating providers. This
research was done by collecting qualitative information in the form of a survey. These
results were gathered and formatted into a table. Common ideas and thoughts, both
positive and negative, were highlighted. The common critiques and practices that would
help to make future recommendations more specialized for this particular hospital site
and these particular anesthesia providers were finally identified.
Interventions and Measures
The expectation for this doctoral project was to provide awareness regarding
opioid use and abuse. The goal was also to educate anesthesia providers on evidence of a
superior means to blunting the sympathetic pathways concurrently supplying
perioperative pain management. More specifically, the best practice recommendation
includes implementing Precedex into practice while synchronously decreasing or
omitting the use of fentanyl. Additionally, this recommendation has the potential to be
beneficial in establishing an evidence-based practice.
An educational summary containing material and researched evidence pertaining
to the practice recommendation was provided to each provider on the expert panel. The
best practice was presented to the panel and an evaluation was presented in the
questionnaire format evaluating the quality, efficacy, and acceptability to change current
16

practice. The data gathered from the evaluations formed the basis of the practice
recommendation. The data was reviewed and analyzed, the practice recommendation was
made, and an executive summary was developed. Key stakeholders received the
deliverables and a presentation was made.
Data and Analysis
A questionnaire was used for data collection. After presenting the information
concerning the recommendation, each member of the expert panel was asked to complete
a questionnaire, providing information and data to make alterations and improve the
practice recommendation. Completed questionnaires determined the final structure of the
best practice recommendation and executive summary. Question one confirmed that the
provider consented to voluntarily agreeing to take the questionnaire. Questions two-five
inquired about the provider’s current anesthetic practice pre-presentation. Questions six
and seven inquired about the information presented to the provider. Questions eight
through ten inquired about potential future practice changes based on the information
received. Question eleven asked for any comments or suggestions concerning the
information. The questionnaire remained completely anonymous, voluntary, and
proposed the following questions:
1. Do you give informed consent to voluntarily agreeing to take this
questionnaire?
2. Do you currently use Precedex as a part of your anesthetic practice? If so,
can you describe your current use of Precedex?
3. Do you currently utilize any other type of multimodal pain management
techniques as a part of your anesthetic practice? If so, please briefly explain.
17

4. Are you aware of the price difference of fentanyl and Precedex at your
facility?
5. Did this doctoral project presentation bring awareness about opioids or
previously unrecognized consequences to the use of opioids?
6. Did this doctoral project presentation provide you with adequate evidencebased information regarding the use of Precedex as a part of a multimodal
pain management technique?
7. Would you consider changing your practice by administering Precedex
perioperatively based on the information presented if given the opportunity?
8. Would you consider decreasing or omitting the use of fentanyl and other
opioids, by substituting them for Precedex or another form of non-opioid
pain management based on the information presented if given the opportunity?
9. Would you consider administering Precedex or another form of a non-opioid
sympatholytic drug in the place of fentanyl during the induction phase in your
anesthetic practice?
10. Please provide any comments or suggestions regarding this best practice
policy recommendation.
Resistance and Barriers to Change
Potential barriers or resistance to change by not accepting the practice
recommendation can result in ethical concern. The proposed practice recommendation
reflects evidence-based best practices for the improvement of safe and satisfactory patient
outcomes. However, CRNAs or anesthesiologists who reject the practice
recommendation, as opposed to those who adopt it into their practice, will be providing
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two different standards of care. The resistance to change can stem from internal or
individual interference. Precedex is a much newer drug when compared to fentanyl and
its use in perioperative anesthesia has just recently become more popular. With that being
said, providers who have been working for many years can be reluctant about changing
their practice. With the proper knowledge, education, and literature reviewed evidencebased data presented with this proposed practice recommendation, this barrier may
potentially be broken. The fear of change may also be alleviated with this doctoral project
by considering the panels’ preferences and suggestions offered by the questionnaire
(Timmermans & Mauck, 2005).
Summary
The goal of this proposed practice recommendation was to provide support and
current evidence on the use of Precedex as an approach to decrease the use of opioids
and improve patient outcomes. The proposed recommendation was presented to the panel
of experts, providing the evidence and support for the use of Precedex. Data from the
questionnaires were compiled and analyzed and potential alterations to the best practice
recommendation were highlighted for future use.
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CHAPTER III - RESULTS
Overview
The inclusion criteria for this doctoral project included CRNA’s at a hospital site
in central Mississippi who provide perioperative care to an extended range of patients
including but not limited to, outpatient, vascular, general, neurologic, and orthopedic
surgery. Exclusion criteria included any CRNA who did not willingly want to participate
in reading the provided material and subsequently completing the attached survey. A
sample size of seven CRNA’s was obtained. The participants were asked to read a threepage handout detailing our evidence-based data on the use of perioperative opioids and
Precedex. They were asked to reflect on their current, past, and/or present use of both
opioids and Precedex in clinical practice. They then were asked to evaluate the
recommendation by completing a ten-question survey.
The data gathered was from the seven willing participants. The survey used is
located in Appendix C. The analysis of each question is located in Table 1. Question one
addressed if the CRNA currently uses Precedex as part of their current anesthetic
practice. Six of the seven participants responded that yes, they do currently use
Precedex, and one of the seven participants responded that they do not use Precedex.
From the data, it was determined that 85.71% had at least minimal prior exposure to
Precedex utilization and 14.29% did not currently use it. Whether they have or have not
ever used the drug in their clinical practice is unknown. Question two asked if the CRNA
currently utilizes any other type of multimodal pain management techniques in their
anesthetic practice. Six out of the seven, or 85.71%, responded that they do utilize other
pain management techniques, while one person, or 14.29%, did not. Question three asked
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if they are aware of the price difference of fentanyl and Precedex at their facility. Six
out of the seven, or 85.71% were not aware, while one person, or 14.29% was.
Table 1
Survey Response to Questions
Question
Do you currently use
Precedex as a part of your
anesthetic practice?
Do you currently use any
other type of multimodal
pain management
techniques as a part of your
anesthetic practice?
Are you aware of the price
difference of fentanyl and
Precedex at your facility?
Did this doctoral project
presentation bring
awareness about opioids or
previously unrecognized
consequences to the use of
opioids?
Did this doctoral project
presentation provide you
with adequate evidencebased information regarding
the use of Precedex as a
part of a multimodal pain
management technique?
Would you consider
changing your practice by
administering Precedex
perioperatively based on the
information presented if
given the opportunity?

Yes
6

No
1

6

1

1

6

6

1

7

0

7

0
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(Table Continued)
Would you consider
7
decreasing or omitting the
use of fentanyl and other
opioids, by substituting
them for Precedex or
another form of non-opioid
pain management based on
the information presented if
given the opportunity?
Would you consider
7
administering Precedex or
another form of a nonopioid sympatholytic drug
in the place of fentanyl
during the induction phase
in your anesthetic practice?
Please provide any
None
comments or suggestions
regarding this best practice
policy recommendation.

0

0

None

Beginning with question four, specific information concerning the provided
material began. Question four inquired as to if the presentation brought them awareness
concerning opioids that was previously unrecognized. Six out of the seven, or 85.71%,
said that it did, while 1 person, or 14.29% said that it did not. Question five asked if the
CRNA’s thought that the presentation provided them with adequate information
regarding the use of Precedex. Seven out of seven participants, or 100%, said that it did.
Question six asked if the participants would consider changing their practice by
administering Precedex based on the information. Seven out of seven participants, or
100%, said that they would. Question seven inquired as to if they would consider
decreasing or abolishing their use of opioids by substituting them with Precedex or
another non-opioid pain management technique based on the information. Seven out of
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seven participants, or 100%, said that they would. Question eight asked if the CRNA
would consider administering Precedex or another non-opioid sympatholytic drug in
place of Fentanyl during anesthetic induction based on the information provided. Seven
out of seven participants, or 100%, said that they would. The final question, question
nine, asked for any suggestions or comments regarding this practice recommendation.
There were no comments or suggestions left by participants.
Summary
The responses to each question were either completely, or almost, unanimously
answered. All participants would support the practice recommendation that was
proposed. Nearly all participants reported they learned something from this information.
No participant had comments or suggestions to provide.
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CHAPTER IV – DISCUSSION
The goal of this doctoral project was to provide CRNAs with evidence-based,
summarized information regarding the use of both Precedex and fentanyl during the
operative period. The research was focused on the administration during the induction
period of anesthesia. Through this, the hope was to either educate, or refresh, providers
on the potential benefits of reducing or eliminating opioids, specifically fentanyl, and
substituting it with Precedex in applicable patient populations. This practice
recommendation was presented and evaluated for completeness, relevancy, and readiness
to be utilized by the CRNAs at the facility. The CRNA’s were to evaluate the practice
recommendation by completing a nine-question survey. The practice recommendation
was unanimously found to be based on evidence-based practice and effective in
persuading providers to consider a practice change.
Implications for Future Doctoral Projects
According to Table 1, participants expressed a willingness to change their
anesthetic practice to include non-opioid pain management techniques, specifically
Precedex, based off of the information that was provided. Their positive response
warrants the need for a specific protocol based on this central Mississippi hospital site’s
patient population and surgical services offered. For example, guidelines for the dose to
administer during a conscious sedation case where Precedex is serving as the sole
anesthetic vs. the dose to administer when Precedex is used as an adjunct to general
anesthesia. Because the availability of the drug has been confirmed, as well as provider
willingness, there would be a benefit to continuing the research towards the goal of a
protocol. This recommendation focused on its use during the induction period. Other
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doctoral projects could focus on Precedex use throughout the entire perioperative
period. Lastly, this doctoral project could be duplicated but focus on other non-opioid
pain management pharmacology, such as Ketamine™.
Limitations
The major limitation of this doctoral project was participation. Participation in
reading the information provided and subsequently taking the survey was optional and
there were no repercussions for choosing to not participate. A sample size of seven was
small. The results would have carried greater accuracy with an increased number of
participants. As many of the survey questions were unanimously answered, an increased
number of participants could have shed light on different thought processes and given us
a wider range of results. Further, no one provided comments or suggestions concerning
the information. Specific comments would have provided information that was unable to
be communicated through the closed answer survey questions. Another limitation was a
combination of both time and the current pandemic health crisis plaguing the world. This
information was not able to be presented to the CRNAs through a physical presentation.
Rather, the information was emailed in an effort to abide by social distancing protocols.
If there had been an extended period to present and receive results, the information could
have potentially been delivered in-person and more effectively communicated.
Dissemination
This doctoral project has been presented to anesthesia providers at a hospital site
in central Mississippi. The recommendation and evidence-based research obtained during
the completion of this doctoral project is available to these anesthesia providers at this
facility through a link via email. The practice recommendation will also be presented to
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academic stakeholders and other students enrolled in the Nurse Anesthesia Program, in
the School of Leadership and Advanced Nursing Practice at The University of Southern
Mississippi.
Recommendations
Future investigations into a specific, facility centered, protocol could potentially
lead to increased perioperative Precedex use and decreased perioperative fentanyl use.
The evidence states that this practice recommendation could negate the side effects
patients experience related to opioid use. Future doctoral projects related to this should
aim to include a larger sample size. If the doctoral project was advanced, more thorough
information regarding the CRNA’s current use of Precedex and fentanyl would be
obtained through in-person shadowing and/or interviews. This central Mississippi
hospital sites’ needs would thereby be assessed. The information provided was found to
be successful in persuading an increase in Precedex use and a decrease in fentanyl use.
Due to this and the willingness expressed by providers to participate in this practice
recommendation, guidance through the form of a protocol could be the safest and most
beneficial way to incorporate the practice recommendation into the anesthesiologist,
CRNA, and patient’s operative experience.
Conclusion
The evolution of healthcare research, safety, and efficacy is a mainstay in today’s
clinical experience. A continued emphasis on this idea is thereby essential to improving
patient care and satisfaction. Beneficence mandates anesthesia providers to act in the best
interest of the patient. Attempting to circumvent the negative side effects of fentanyl
could prove to be monumental to certain patients. Consideration and application of the
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information provided in this practice recommendation serve as a potential means of
accomplishing not only this, but superior patient satisfaction, pain control, and
homeostasis. Healthcare facilities all over are being encouraged to incorporate non-opioid
anesthetic techniques into their practice. The options are extensive and often mandate a
learning curve. This doctoral project hopes to serve as a starting point for one easily
accessible option. This doctoral project presented a recommendation on Precedex use
through a three-page handout to a hospital site in central Mississippi with the goal of
those participating to consider applying the information in their daily clinical setting.
Participants expressed their willingness to incorporate our recommendation into their
anesthetic practice. Future doctoral projects at this facility could begin to develop a
hospital-specific protocol for safe Precedex use, ideally using a larger sample size of
CRNA participants.
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APPENDIX A – Literature Matrix
Author/Year/
Title
Armaghani et
al., 2014
Preoperative
opioid use and
its association
with
perioperative
opioid demand
and
postoperative
opioid
independence in
patients
undergoing
spine surgery.

Design

Sample/Data
Collection
Prospective 583 patients
Cohortself-reported
Quantitativ daily opioid
e
consumption
obtained
preoperatively
and converted
into morphine
equivalent
amounts and
opioid use was
recorded 12
months
postoperatively.

Findings
The median
preoperative
use was 8.75
mg. Younger
age, more
invasive
procedures, and
anxiety were
found to be
associated with
increased
postoperative
opioid demand.

Recommendatio
ns
Patients would
benefit from
preoperative
counseling on
opioid use and
abuse.

Gaszynski et al., Qualitative
2014
Dexmedetomidi
ne for awake
intubation and
opioid-free
general
anesthesia in a
superobese
patient with
suspected
difficult
intubation.

One 39-year-old
female patient
with a BMI of
62.3 underwent
an awake
intubation using
topical
anesthesia and
dexmedetomidi
ne. Subsequent
anesthesia
difficulty was
then assessed.

No additional
opioids were
required, the
patient quickly
emerged, and
the patient
remained
hemodynamical
ly stable.

Dexmedetomidin
e may help
minimize or
eliminate the
intraoperative
use of opioids.

Gupta et al.,
2018
A comparative
evaluation of
the use of
dexmedetomidi
ne versus
fentanyl for
anesthesia

140 healthy
patients with
ASA of I and II
were given
either
Precedex or
fentanyl prior to
LMA insertion.
Vitals were

The patients
who received
Precedex
showed a
decrease in HR,
SBP, DBP, and
MAP following
LMA insertion.
Those who

Precedex
provides a
beneficial effect
in attenuation of
hemodynamic
response to LMA
insertion as
compared to
fentanyl.

Quantitativ
e; a
prospective
, doubleblind,
randomize
d study
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induction with
propofol for
insertion of
laryngeal mask
airway.

subsequently
monitored.

Naaz & Ozair,
2014
Dexmedetomidi
ne in current
anesthesia
practice- a
review

Review
Article

Compilation
and review of
numerous
evidence-based
resources.

Stanley, 2014
The Fentanyl
Story

Review
Article

Compilation
and review of
numerous
evidence-based
resources.
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received
Fentanyl
showed an
increase. Apnea
time was
shorter in
patients who
received
Precedex.
Precedex is a n/a
useful addition
to anesthesia. It
has a wide
range of use yet
requires
vigilance when
in use. The
high cost is also
something to
note.
Fentanyl has
n/a
become one of
the most
important
opioids in
anesthesia due
to its multiple
formulations,
potency,
familiarity, and
physical
characteristics.

APPENDIX B – Doctoral Project Handout
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APPENDIX C – IRB Approval Letter
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APPENDIX D – Panel of Experts Survey
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APPENDIX E – Facility Permission Request
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APPENDIX F –DNP Essentials
DNP Essentials

Clinical Implications

Essential One: Scientific
Underpinnings for Practice

Identification of the current
use of fentanyl and
Precedex during
anesthesia induction
Interaction with anesthesia
providers to produce a more
standardized utilization of
Precedex
Literature analysis to gather
and compile relevant data
regarding potential
pharmaceutical use
The literature included in
this doctoral project was
retrieved through the
utilization of technology.
The aim was to project
positive patient outcomes
by compiling this data.
This doctoral project
advocated for increased
patient safety and patient
satisfaction. The results
include but are not limited
to aiding the opioid crisis
and decreasing recovery
times.
Through the survey tool,
input was sought from
seasoned anesthesia
providers. This is a
collaboration of experience
among students and
providers is one that
evidence-based research
cannot provide.
Long term goals of this
doctoral project include
decreased opioid
overuse/abuse along with

Essential Two: Organizational
and Systems Leadership for
Quality Improvement and
Systems Thinking
Essential Three: Clinical
Scholarship and Analytical
Methods for Evidence-Based
Practice
Essential Four: Information
Systems/Technology and
Patient Care Technology for
the Improvement and
Transformation of Health Care

Essential Five: Health Care
Policy for Advocacy in Health
Care

Essential Six: Interprofessional
Collaboration for Improving
Patient and Population Health
Outcomes

Essential Seven: Clinical
Prevention and Population
Health for Improving the
Nation’s Health
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sentential events associated
with it.
Evidence and literature
review, data synthesis,
evaluation of data, and
assessment of data postpresentation.

Essential Eight: Advanced
Nursing Practice
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